Principali concorrenti
P/E ratio (Y) Price to Book (Y) PEG (Y) EV/Fatturato (Y) EV / EBITDA (Y) EV / EBIT (Y) Rendimento (Y) Capi.($)
- - - - - - - 12,41 Mln
45.97x7.26x2.06x10.92x39.12x40.38x0,02% 49,27 Mrd
18.09x4.33x0.24x6.45x14.35x15.8x1,6% 44,15 Mrd
-27.24x93x-3.52x62.44x-30.44x-29.42x-.--% 34,86 Mrd
-27.63x1.26x-1.24x4.79x-13.08x-10.34x-.--% 27,38 Mrd
33.11x3.07x0.86x6.55x18.16x22.61x-.--% 21,21 Mrd
19.16x3.63x-5.98x4.92x12.9x13.86x-.--% 21,63 Mrd
-202.83x24.86x-2.58x48.32x-195.77x-173.36x-.--% 13,95 Mrd
-459.52x13.39x7.66x29.32x608.28x-489.85x-.--% 14,58 Mrd
-13.59x - -0.05x170.31x-26.56x-13.29x-.--% 13,61 Mrd
17.35x4.66x0.36x4.98x12.33x13.6x-.--% 12,18 Mrd
-48x19.01x0.92x11.52x-44.97x-43.21x-.--% 11,47 Mrd
-18.71x16.56x-0x20.8x-26.35x-18.91x-.--% 9,06 Mrd
-163.4x20.27x2.01x18.85x330.82x-130.32x-.--% 7,66 Mrd
-18.85x8.12x-0.41x - -19.41x-18.75x-.--% 8,37 Mrd
-10.16x-14.07x-0.49x92.3x-12.43x-12.18x-.--% 7,9 Mrd
813.26x42.88x-6.75x98.06x882.1x1141.06x - 7,23 Mrd
Media -2,69x 16,55x -0,43x 39,37x 96,82x 19,23x 0,11% 17,91 Mrd
Media ponderata per Capi. -11,02x 18,42x -0,35x 29,58x 51,33x -3,55x 0,24%
Farmaci bioterapeutici